Search Results - "Kurz, Ken D."
-
1
Engineering the Proteolytic Specificity of Activated Protein C Improves Its Pharmacological Properties
Published in Proceedings of the National Academy of Sciences - PNAS (15-04-2003)“…Human activated protein C (APC) is an antithrombotic, antiinflammatory serine protease that plays a central role in vascular homeostasis, and activated…”
Get full text
Journal Article -
2
Evidence that Blood Pressure Reduction by Serotonin Antagonists is Related to Alpha Receptor Blockade in Spontaneously Hypertensive Rats
Published in Hypertension (Dallas, Tex. 1979) (01-09-1983)“…In vitro affinity for vascular 5HT and alpha receptors was determined for several compounds (spiperone, ketanserin, mianserin, trazodone, mepiprazole,…”
Get full text
Journal Article -
3
Pinacidil-induced vascular relaxation: comparison to other vasodilators and to classical mechanisms of vasodilation
Published in Journal of cardiovascular pharmacology (1988)“…Pinacidil is a potent antihypertensive agent in animals and humans. In conscious spontaneously hypertensive rats after oral administration, pinacidil was…”
Get more information
Journal Article -
4
Antithrombotic efficacy in the guinea pig of a derivative of human protein C with enhanced activation by thrombin
Published in Blood (15-01-1997)“…Conversion by alpha-thrombin of the zymogen human protein C (HPC) to activated protein C (aPC) is an important physiologic feedback control mechanism for the…”
Get full text
Journal Article -
5
Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67
Published in European journal of pharmacology (05-06-1986)“…Xylamidine and BW501C67 (alpha-anilino-N-2-m-chlorophenoxypropylacetamidine), serotonin antagonists that have been reported not to cross the blood-brain…”
Get more information
Journal Article -
6
Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR
Published in Clinical and experimental hypertension. Part A, Theory and practice (1987)“…mCPP (meta-chlorophenylpiperazine) has agonist activity at some central serotonin receptors and antagonist activity at peripheral vascular 5HT2 receptors, both…”
Get more information
Journal Article